{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:58:20Z","timestamp":1794333500189,"version":"4.9.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Monitoring the progression of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs) is crucial for evidence-based decision-making in prevention and control strategies. This study aimed to delineate the global, regional, and national burden of these infections from 1990 to 2021 and forecast trends to 2030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrieved data from the Global Burden of Disease (GBD) study 2021, including incidence and disability-adjusted life-years (DALYs) of HIV and other STIs from 1990 to 2021. Trends were quantified using estimated annual percentage changes (EAPCs) in age-standardized incidence and DALY rates. The Bayesian age-period-cohort (BAPC) model was used to forecast the future burden from 2022 to 2030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, global epidemiological surveillance documented 1,645,333 incident cases of HIV and 722,752,642 incident cases of other STIs. Concurrently, the burden of disease analysis revealed 40,266,792 DALYs attributable to HIV and 7,953,311 DALYs linked to STIs worldwide. The global age-standardized incidence rate (ASIR) of HIV declined from 36.7 (95% uncertainty interval [UI]: 33.0\u201340.6) per 100,000 population in 1990 to 20.7 (95% UI: 17.7\u201324.4) in 2021 per 100,000 population, with an EAPC of \u22122.58% (95% confidence interval [CI]: \u22122.95% to \u22122.20%). In contrast, the ASIR of other STIs remained relatively stable, changing from 8692.6 (95% UI: 6256.5\u201311,811.2) per 100,000 in 1990 to 8871.7 (95% UI: 6388.4\u201312,055.1) per 100,000 in 2021, with an EAPC of \u22120.02% (95% CI: \u20130.07% to 0.03%). The BAPC model predicts a decline in the ASIR of HIV to 12.9 (95% UI: 4.3\u201321.5) per 100,000 by 2030, whereas the ASIR of other STIs is expected to increase to 9150.0 (95% UI: 7913.6\u201310,386.3) per 100,000. Regionally, Sub-Saharan Africa is projected to have the highest ASIRs of HIV and other STIs in 2030, with estimates of 38.4 (95% UI: 11.7\u201365.2) and 13,865.8 (95% UI: 11,915.6\u201315,816.0) per 100,000 population, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Despite declining HIV ASIRs, DALY burdens remain high, with significant regional disparities. HIV and other STIs continue to pose major public health challenges, necessitating targeted interventions, early sexual health education, enhanced screening, and cost-effective policies informed by GBD 2021 data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003867","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:00:15Z","timestamp":1764763215000},"page":"3434-3442","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Global, regional, and national burden of HIV and other sexually transmitted infections, 1990\u20132021, and forecasts to 2030: A population-based analysis based on the Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"138","author":[{"given":"Zhenhao","family":"Wu","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, Liaoning 110001, China"},{"name":"Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfeng","family":"Yue","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, Liaoning 110001, China"},{"name":"Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Chu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, Liaoning 110001, China"},{"name":"Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, Liaoning 110001, China"},{"name":"Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Hu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Centre for Laboratory Medicine, The First Hospital of China Medical University, China Medical University, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, Liaoning 110001, China"},{"name":"Key Laboratory of AIDS Immunology of Liaoning Province, Shenyang, Liaoning 110001, China"},{"name":"Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"R1-20260407","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R2-20260407","doi-asserted-by":"crossref","first-page":"e39834","DOI":"10.1371\/journal.pone.0039834","article-title":"HIV and other sexually transmitted infections among men who have sex with men recruited by RDS in Buenos Aires, Argentina: High HIV and HPV infection","volume":"7","author":"Pando","year":"2012","journal-title":"PLoS One"},{"key":"R5-20260407","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1473-3099(21)00448-5","article-title":"Global burden and trends of sexually transmitted infections from 1990 to 2019: An observational trend study","volume":"22","author":"Zheng","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R8-20260407","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/S2352-3018(21)00127-2","article-title":"Adoption of guidelines on and use of oral pre-exposure prophylaxis: A global summary and forecasting study","volume":"8","author":"Schaefer","year":"2021","journal-title":"Lancet HIV"},{"key":"R11-20260407","doi-asserted-by":"crossref","first-page":"e1002678","DOI":"10.1371\/journal.pmed.1002678","article-title":"Epidemiological metrics and benchmarks for a transition in the HIV epidemic","volume":"15","author":"Ghys","year":"2018","journal-title":"PLoS Med"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1097\/CM9.0000000000002500","article-title":"Changes of human immunodeficiency virus (HIV) burden globally and in China over three decades: A secondary analysis of global HIV statistics","volume":"135","author":"Lu","year":"2022","journal-title":"Chin Med J"},{"key":"R13-20260407","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40249-024-01247-8","article-title":"Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data","volume":"13","author":"Lv","year":"2024","journal-title":"Infect Dis Poverty"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/jama.1997.03540480062040","article-title":"Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel","volume":"277","author":"Carpenter","year":"1997","journal-title":"JAMA"},{"key":"R17-20260407","doi-asserted-by":"crossref","first-page":"e2148782","DOI":"10.1001\/jamanetworkopen.2021.48782","article-title":"Association of HIV preexposure prophylaxis use with HIV incidence among men who have sex with men in China: A nonrandomized controlled trial","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R18-20260407","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): A multicentre, open-label, randomised trial with a 2\u2008\u00d7\u20082 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R20-20260407","doi-asserted-by":"crossref","first-page":"04105","DOI":"10.7189\/jogh.14.04105","article-title":"The trend analysis of HIV and other sexually transmitted infections among the elderly aged 50 to 69 years from 1990 to 2030","volume":"14","author":"Liang","year":"2024","journal-title":"J Glob Health"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3018(21)00152-1","article-title":"Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990\u20132019, for 204 countries and territories: The Global Burden of Diseases Study 2019","volume":"8","year":"2021","journal-title":"Lancet HIV"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s10461-020-02914-1","article-title":"A systematic review of HIV interventions for young women in Sub-Saharan Africa","volume":"24","author":"Muthoni","year":"2020","journal-title":"AIDS Behav"},{"key":"R26-20260407","doi-asserted-by":"crossref","first-page":"548P","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","article-title":"Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10\u201324 years from 1990 to 2019: A trend analysis based on the Global Burden of Disease Study 2019","volume":"6","author":"Zhang","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R28-20260407","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2666-7568(23)00214-3","article-title":"Global, regional, and national burden of HIV and other sexually transmitted infections in older adults aged 60\u201389 years from 1990 to 2019: Results from the Global Burden of Disease Study 2019","volume":"5","author":"Fu","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"R29-20260407","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/sti.2007.026245","article-title":"Sexually transmitted diseases in the USA: Temporal trends","volume":"83","author":"Aral","year":"2007","journal-title":"Sex Transm Infect"},{"key":"R30-20260407","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/S2352-3018(19)30196-1","article-title":"Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017","volume":"6","year":"2019","journal-title":"Lancet HIV"},{"key":"R31-20260407","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1016\/S2214-109X(23)00588-0","article-title":"Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: A mathematical modelling study","volume":"12","author":"Chevalier","year":"2024","journal-title":"Lancet Glob Health"},{"key":"R32-20260407","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jadohealth.2022.10.030","article-title":"Barber-led HIV\/sexually transmitted infection risk reduction for young African-American men: Efficacy and mediation in a cluster randomized controlled trial","volume":"72","author":"Jemmott","year":"2023","journal-title":"J Adolesc Health"},{"key":"R33-20260407","doi-asserted-by":"crossref","first-page":"1320080","DOI":"10.3389\/fpubh.2023.1320080","article-title":"Editorial: Addressing the sexually transmitted infections epidemic in the United States: A sociomedical perspective","volume":"11","author":"Williams","year":"2023","journal-title":"Front Public Health"},{"key":"R34-20260407","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1016\/S2352-3018(23)00224-2","article-title":"Programme science: A route to effective coverage and population-level impact for HIV and sexually transmitted infection prevention","volume":"10","author":"McClarty","year":"2023","journal-title":"Lancet HIV"},{"key":"R35-20260407","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/apc.2022.0220","article-title":"Impact of COVID-19 on sexually transmitted infection and HIV screening at an urban safety-net hHospital","volume":"37","author":"Lescure","year":"2023","journal-title":"AIDS Patient Care STDS"},{"key":"R36-20260407","first-page":"127","article-title":"Rebound in sexually transmitted infections after the COVID-19 pandemic","volume":"26","author":"Soriano","year":"2023","journal-title":"AIDS Rev"},{"key":"R37-20260407","first-page":"124","article-title":"Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic","volume":"99","author":"Ghaznavi","year":"2023","journal-title":"Sex Transm Infect"},{"key":"R38-20260407","doi-asserted-by":"crossref","first-page":"e1285","DOI":"10.1093\/milmed\/usab479","article-title":"The prevalence of sexually transmitted infections and sociosexual behaviors in the South Korean military before and during the COVID-19 pandemic","volume":"188","author":"Oh","year":"2023","journal-title":"Mil Med"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:51Z","timestamp":1775592171000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003867","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"2025-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}